Mine & Arao Wealth Creation & Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
MSCM
ACA
RW
Mine & Arao Wealth Creation & Management's IHE Position: Q2 2024 in Review
Mine & Arao Wealth Creation & Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2024, closing a stake of 1,710 shares — an estimated $116K sold.
Mine & Arao Wealth Creation & Management first reported a position in IHE in Q4 2019 and held it in 18 quarters. The position peaked at $116K in Q1 2024. 143 funds tracked by Wall St. Rank hold IHE as of Q2 2024.
- Mine & Arao Wealth Creation & Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2024 after selling out during the quarter.
- Mine & Arao Wealth Creation & Management sold 1,710 iShares US Pharmaceuticals ETF shares in Q2 2024, an estimated $116K.
- Mine & Arao Wealth Creation & Management first reported a position in iShares US Pharmaceuticals ETF in Q4 2019 and held it in 18 quarters.
- Mine & Arao Wealth Creation & Management's iShares US Pharmaceuticals ETF position peaked at $116K in Q1 2024.
- 143 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2024.
Based on Mine & Arao Wealth Creation & Management's 13F filing for Q2 2024, filed 6 Aug 2024.